M6766
M6766 is a selective endoplasmic reticulum oxidoreductase 1α (ERO1α) inhibitor with an IC50 of 1.4 μM and a KD of 1.1 μM. M6766 also inhibits ERO1β with an IC50 of 7.2 μM. M6766 binds to the flavin adenine dinucleotide-binding pocket in ERO1α. M6766 inhibits granule secretion, αIIbβ3 integrin activation, Ca2+ mobilization, and platelet aggregation. M6766 can be used for the research of neurological disease, such as ischemic stroke[1].
Product Specifications
CAS Number
696628-90-7
UNSPSC
12352100
Target
Endoplasmic Reticulum Oxidoreductase 1 (ERO1) ; Reactive Oxygen Species (ROS)
Related Pathways
Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Smiles
CN1C(SC2=C3CCCCC3=C(C4=NC5=CC=CC=C5N42)C#N)=NN=C1
Molecular Formula
C19H16N6S
Molecular Weight
360.44
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Chicken Human IgG (H/L) Absorbed against Mouse, Goat and Rabbit IgG Antibody
IL-3Rbeta, phosphorylated (Y593) (Cytokine Receptor common Subunit beta, CDw131, GM-CSF/IL-3/IL-5 Receptor common beta Subunit, CD131, CSF2RB, IL3RB, IL5RB, IL3Rb) discontinued
IL-3Rbeta, phosphorylated (Y593) (Cytokine Receptor common Subunit beta, CDw131, GM-CSF/IL-3/IL-5 Receptor common beta Subunit, CD131, CSF2RB, IL3RB, IL5RB, IL3Rb) discontinued
LGALS1 (Galectin-1, Lectin, Galactoside-Binding, Soluble, 1)
